<DOC>
	<DOCNO>NCT00362388</DOCNO>
	<brief_summary>This study design test hypothesis direct injection bone-marrow cell heart may increase number blood vessel , ameliorate heart 's performance , relieve patient symptom like angina and/or shortness breath .</brief_summary>
	<brief_title>Cell Therapy Chronic Ischemic Heart Disease</brief_title>
	<detailed_description>Severe ischemic heart disease ( IHD ) remain clinical challenge ; many patient IHD undergone myocardial revascularization procedure ( either percutaneous surgical ) still remain symptomatic despite maximally tolerate medical therapy . Others consider non-optimal candidate complete myocardial revascularization procedure due extension diffuseness disease . Cell therapy autologous bone marrow-derived cell ( BMC ) novel therapeutic strategy test many cardiovascular disease , include heart failure , acute myocardial infarction , chronic ischemic heart disease . The primary objective study assess efficacy intramyocardial injection autologous BMC myocardial perfusion leave ventricular function adjunctive therapy ( compare placebo ) patient undergo coronary artery bypass surgery ( CABG ) . The secondary objective study assess effect intramyocardial injection autologous BMC functional class ( angina/heart failure ) , functional capacity , global cardiovascular mortality , quality life patient undergoing coronary artery bypass surgery ( CABG ) .</detailed_description>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Heart Diseases</mesh_term>
	<criteria>Diagnosis chronic , severe , diffuse , multivessel atherosclerotic coronary artery disease ( CAD ) refer CABG . Echocardiogramassessed LVEF 25 55 % ( Simpson 's rule ) . Angina ( equivalent ) functional class II IV ( Canadian Cardiovascular Society ) despite maximally tolerate medical therapy . Abnormal myocardial perfusion test : i. Cardiac scintigraphy ii . Magnetic resonance imaging iii . Dobutamineatropine stressechocardiogram Noncandidates percutaneous coronary intervention ( PCI ) due ANY following : . High risk lesion ii . Extensive lesion iii . Diffuse , small vessel disease Noncandidates complete CABG , candidate complete CABG , accord expert panel , high probability failure graft due extension severity disease , diffuse , small vessel involvement . To provide sign , write informed consent , accord National Guidelines Clinical Trials . Severe valve heart disease require surgical repair . Serologic diagnostic Chagas ' disease . Symptoms heart failure , even ischemic etiology , absence objectively document myocardial ischemia . Malignant ventricular arrhythmia ( like VT ) , unless ICD place . Any acute coronary syndrome past 3 month . Endstage renal disease require maintenance dialysis . History neoplasia . Drug alcohol abuse . Life expectancy 2 year . Enrollment cell therapy trial past 2 year .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2008</verification_date>
	<keyword>Coronary artery disease</keyword>
	<keyword>Ischemic heart disease</keyword>
	<keyword>Angiogenesis</keyword>
	<keyword>Cells</keyword>
	<keyword>Cardiac surgery</keyword>
</DOC>